DRREDDYDr. Reddy's Laboratories
Pharma · Pharmaceuticals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Dr. Reddy's Laboratories operates in the Pharmaceuticals space within the Pharma sector.
₹1,310.90
▲ 6.62%Decent
Mkt Cap
₹1.09L Cr
P/E
33.1
P/B
2.9
Div Yield
0.60%
52W High
₹1,405.98
52W Low
₹1,101.00
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,09,198.10
P/E33.05
P/B2.89
PEG1.83
ROE %8.84
ROCE %11.00
Debt / Equity0.19
EPS39.66
Revenue Growth %-5.60
Profit Growth %-68.70
Dividend Yield %0.60
Promoter Holding %30.13
FII Holding %51.94
DII Holding %—
Beta0.24
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
HOLDConviction 64%
The picture
- • Debt/Equity: 0.19
- • Valuation vs sector: P/E 33.0 vs sector 35.5
- • RSI: 71
- • MACD: bullish
- • Price vs EMA21: above
- • 1-month vs NIFTY: +12.2% relative
- • Bollinger Squeeze signal (setup quality 69%)
- • Breakout with Volume signal (setup quality 88%)
Bull case
- • Debt/Equity: 0.19
- • Valuation vs sector: P/E 33.0 vs sector 35.5
- • RSI: 71
- • MACD: bullish
Bear case
- • Revenue growth: -5.6% YoY
- • Profit growth: -68.7% YoY
- • Golden cross setup: SMA50 below SMA200
- • Trend strength (ADX): 16
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: -5.6% YoY
- • Profit growth: -68.7% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹1,310.90
Stop Loss
₹1,233.22
risk 5.9%
Target 1 (1.5R)
₹1,427.42
+8.9%
Target 2 (3R)
₹1,543.94
+17.8%
Support (20d)
₹1,167.20
Resistance (52w)
₹1,405.98
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹77.68/share
ATR (volatility)
₹31.07
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹31.07). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental36
Technical73
Momentum70
Risk (safety)79